Royal Bank of Canada »

Skye Bioscience shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Skye Bioscience (SKYE) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Skye Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Skye Bioscience held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Skye Bioscience by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-09-30 $0 1.9k 0.00
2024-06-30 $0 1.7k 0.00

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Bk Nova Cad (BNS)
Ishares Tr Russell 2000 Etf (IWM)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Enbridge (ENB)
Cibc Cad (CM)

View all positions for Royal Bank of Canada

Top funds holding Skye Bioscience

5AM Venture Management
Versant Venture Management
Baker Bros. Advisors
Altium Capital Management
Logos Global Management
Sphera Funds Management
BlackRock
BlackRock
Schonfeld Strategic Advisors
Henderson Group
Ensign Peak Advisors
Vanguard Group
CVI Holdings
Driehaus Capital Management
Alyeska Investment Group

View all funds holding Skye Bioscience